1RMJ

C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II.

Headey, S.J.Keizer, D.W.Yao, S.Brasier, G.Kantharidis, P.Bach, L.A.Norton, R.S.

(2004) Mol.Endocrinol. 18: 2740-2750

  • DOI: 10.1210/me.2004-0248

  • PubMed Abstract: 
  • IGFs are important mediators of growth. IGF binding proteins (IGFBPs) 1-6 regulate IGF actions and have IGF-independent actions. The C-terminal domains of IGFBPs contribute to high-affinity IGF binding and modulation of IGF actions and confer some IG ...

    IGFs are important mediators of growth. IGF binding proteins (IGFBPs) 1-6 regulate IGF actions and have IGF-independent actions. The C-terminal domains of IGFBPs contribute to high-affinity IGF binding and modulation of IGF actions and confer some IGF-independent properties, but understanding how they achieve this has been constrained by the lack of a three-dimensional structure. We therefore determined the solution structure of the C-domain of IGFBP-6 using nuclear magnetic resonance (NMR). The domain consists of a thyroglobulin type 1 fold comprising an alpha-helix followed by a loop, a three-stranded antiparallel beta-sheet incorporating a second loop, and finally a disulfide-bonded flexible third loop. The IGF-II binding site on the C-domain was identified by examining NMR spectral changes upon complex formation. It consists of a largely hydrophobic surface patch involving the alpha-helix, the first beta-strand, and the first and second loops. The site was confirmed by mutagenesis of several residues, which resulted in decreased IGF binding affinity. The IGF-II binding site lies adjacent to surfaces likely to be involved in glycosaminoglycan binding of IGFBPs, which might explain their decreased IGF affinity when bound to glycosaminoglycans, and nuclear localization. Our structure provides a framework for understanding the roles of IGFBP C-domains in modulating IGF actions and conferring IGF-independent actions, as well as ultimately for the development of therapeutic IGF inhibitors for diseases including cancer.


    Related Citations: 
    • 1H, 13C and 15N resonance assignments of the C-terminal domain of insulin-like growth factor binding protein-6 (IGFBP-6).
      Headey, S.J.,Yao, S.,Parker, N.J.,Kantharidis, P.,Bach, L.A.,Norton, R.S.
      (2003) J.Biomol.NMR 25: 251
    • C-Terminal Domain of Insulin-like Growth Factor (IGF) Binding Protein 6: Conformational Exchange and Its Correlation with IGF-II Binding
      Yao, S.,Headey, S.J.,Keizer, D.W.,Bach, L.A.,Norton, R.S.
      (2004) Biochemistry 43: 11187
    • Binding site for the C-domain of insulin-like growth factor (IGF) binding protein-6 on IGF-II; implications for inhibition of IGF actions.
      Headey, S.J.,Keizer, D.W.,Yao, S.,Wallace, J.C.,Bach, L.A.,Norton, R.S.
      (2004) Febs Lett. 568: 19


    Organizational Affiliation

    The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville 3050, Australia.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Insulin-like growth factor binding protein 6
A
107Homo sapiensMutation(s): 0 
Gene Names: IGFBP6 (IBP6)
Find proteins for P24592 (Homo sapiens)
Go to Gene View: IGFBP6
Go to UniProtKB:  P24592
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 
  • Olderado: 1RMJ Olderado

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2004-09-14
    Type: Initial release
  • Version 1.1: 2008-04-29
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Version format compliance